52
Views
3
CrossRef citations to date
0
Altmetric
Review

Management of aortic valve disease in the presence of left ventricular dysfunction

, &
Pages 259-268 | Published online: 10 Jan 2014

References

  • Sarris GE, Cahill PD, Hansen DE, Derby GC, Miller DC. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J. Thorac. Cardiovasc. Surg.95(6), 969–979 (1988).
  • Spoor MT, Bolling SF. Valve pathology in heart failure: which valves can be fixed?. Heart Fail. Clin.3(3), 289–298 (2007).
  • Lung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J.24(13), 1231–1243 (2003).
  • Ramaraj R, Sorrell VL. Degenerative aortic stenosis. BMJ.336(7643), 550–555 (2008).
  • Cosmi JE, Kort S, Tunick PA et al. The risk of the development of aortic stenosis in patients with ‘benign’ aortic valve thickening. Arch. Intern. Med.162(20), 2345–2347 (2002).
  • Dal-Bianco JP, Khandheria BK, Mookadam F, Gentile F, Sengupta PP. Management of asymptomatic severe aortic stenosis. J. Am. Coll. Cardiol.52(16), 1279–1292 (2008).
  • Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet368(9540), 1005–1011 (2006).
  • Rosenhek R, Klaar U, Schemper M et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur. Heart J.25(3), 199–205 (2004).
  • Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol.29(3), 630–634 (1997).
  • Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol.48(3), e1–e148 (2006).
  • Carabello BA. Aortic stenosis: from pressure overload to heart failure. Heart Fail. Clin.2(4), 435–442 (2006).
  • Zile MR, Gaasch WH. Heart failure in aortic stenosis – improving diagnosis and treatment. N. Engl. J. Med.348(18), 1735–1736 (2003).
  • Bergler-Klein J, Klaar U, Heger M et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation109(19), 2302–2308 (2004).
  • Baumgartner H. Aortic stenosis: medical and surgical management. Heart91(11), 1483–1488 (2005).
  • Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J. Am. Coll. Cardiol.15(5), 1012–1017 (1990).
  • Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation111(24), 3290–3295 (2005).
  • Blais C, Burwash IG, Mundigler G et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation113(5), 711–721 (2006).
  • Burwash IG. Low-flow, low-gradient aortic stenosis: from evaluation to treatment. Curr. Opin. Cardiol.22(2), 84–91 (2007).
  • Quere JP, Monin JL, Levy F et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation113(14), 1738–1744 (2006).
  • deFilippi CR, Willett DL, Brickner ME et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am. J. Cardiol.75(2), 191–194 (1995).
  • Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation106(7), 809–813 (2002).
  • Burwash IG, Hay KM, Chan KL. Hemodynamic stability of valve area, valve resistance, and stroke work loss in aortic stenosis: a comparative analysis. J. Am. Soc. Echocardiogr.15(8), 814–822 (2002).
  • Blais C, Pibarot P, Dumesnil JG, Garcia D, Chen D, Durand LG. Comparison of valve resistance with effective orifice area regarding flow dependence. Am. J. Cardiol.88(1), 45–52 (2001).
  • Burwash IG, Thomas DD, Sadahiro M et al. Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in valvular aortic stenosis. Circulation89(2), 827–835 (1994).
  • Clavel MA, Fuchs C, Burwash IG et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation118(14 Suppl.), S234–S242 (2008).
  • Monin JL, Quere JP, Monchi M et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation108(3), 319–324 (2003).
  • Zuppiroli A, Mori F, Olivotto I, Castelli G, Favilli S, Dolara A. Therapeutic implications of contractile reserve elicited by dobutamine echocardiography in symptomatic, low-gradient aortic stenosis. Ital. Heart J.4(4), 264–270 (2003).
  • Schwammenthal E, Vered Z, Moshkowitz Y et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest119(6), 1766–1777 (2001).
  • Levy F, Laurent M, Monin JL et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J. Am. Coll. Cardiol.51(15), 1466–1472 (2008).
  • Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation115(22), 2856–2864 (2007).
  • Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J. Am. Coll. Cardiol.47(11), 2141–2151 (2006).
  • Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J.28(2), 230–268 (2007).
  • Khot UN, Novaro GM, Popovic ZB et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N. Engl. J. Med.348(18), 1756–1763 (2003).
  • Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol.47(6), 1214–1223 (2006).
  • Sharma UC, Barenbrug P, Pokharel S, Dassen WR, Pinto YM, Maessen JG. Systematic review of the outcome of aortic valve replacement in patients with aortic stenosis. Ann. Thorac. Surg.78(1), 90–95 (2004).
  • Connolly HM, Oh JK, Schaff HV et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction: result of aortic valve replacement in 52 patients. Circulation101(16), 1940–1946 (2000).
  • Monin JL, Monchi M, Gest V, Duval-Moulin AM, Dubois-Rande JL, Gueret P. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J. Am. Coll. Cardiol.37(8), 2101–2107 (2001).
  • Powell DE, Tunick PA, Rosenzweig BP et al. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch. Intern. Med.160(9), 1337–1341 (2000).
  • Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation108(8), 983–988 (2003).
  • Kulik A, Burwash IG, Kapila V, Mesana TG, Ruel M. Long-term outcomes after valve replacement for low-gradient aortic stenosis: impact of prosthesis-patient mismatch. Circulation114(1 Suppl.), I553–558 (2006).
  • Collinson J, Flather M, Coats AJ, Pepper JR, Henein M. Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis. Int. J. Cardiol.97(3), 535–541 (2004).
  • Cohen G, David TE, Ivanov J, Armstrong S, Feindel CM. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J. Thorac. Cardiovasc. Surg.117(2), 273–284 (1999).
  • Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation82(1), 124–139 (1990).
  • Vanky FB, Hakanson E, Tamas E, Svedjeholm R. Risk factors for postoperative heart failure in patients operated on for aortic stenosis. Ann. Thorac. Surg.81(4), 1297–1304 (2006).
  • Bonow RO. Aortic regurgitation. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Valvular Heart Disease (Volume 2, 7th edition). Zipes D (Ed.). WB Saunders, PA, USA, 1553–1632 (2005).
  • Enriquez-Sarano M, Tajik AJ. Clinical practice. Aortic regurgitation. N. Engl. J. Med.351(15), 1539–1546 (2004).
  • Rigolin VH, Bonow RO. Hemodynamic characteristics and progression to heart failure in regurgitant lesions. Heart Fail. Clin.2(4), 453–460 (2006).
  • Singh JP, Evans JC, Levy D et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am. J. Cardiol.83(6), 897–902 (1999).
  • Lebowitz NE, Bella JN, Roman MJ et al. Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study. J. Am. Coll. Cardiol.36(2), 461–467 (2000).
  • Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J. Am. Coll. Cardiol.30(3), 746–752 (1997).
  • Bonow RO. Chronic aortic regurgitation. Role of medical therapy and optimal timing for surgery. Cardiol. Clin.16(3), 449–461 (1998).
  • Bonow RO. Radionuclide angiography in the management of asymptomatic aortic regurgitation. Circulation84(3 Suppl.), I296–I302 (1991).
  • Stewart WJ. Optimal timing of surgery in aortic regurgitation. Heart Fail. Clin.2(4), 461–471 (2006).
  • Zoghbi WA, Enriquez-Sarano M, Foster E et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr.16(7), 777–802 (2003).
  • Borer JS, Hochreiter C, Herrold EM et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation97(6), 525–534 (1998).
  • Chaliki HP, Mohty D, Avierinos JF et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation106(21), 2687–2693 (2002).
  • Chukwuemeka A, Rao V, Armstrong S, Ivanov J, David T. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. Eur. J. Cardiothorac. Surg.29(2), 133–138 (2006).
  • Kamath AR, Varadarajan P, Turk R et al. Survival in patients with severe aortic regurgitation and severe left ventricular dysfunction is improved by aortic valve replacement: results from a cohort of 166 patients with an ejection fraction < or = 35%. Circulation120(11 Suppl.), S134–S138 (2009).
  • Scognamiglio R, Negut C, Palisi M, Fasoli G, Dalla-Volta S. Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J. Am. Coll. Cardiol.45(7), 1025–1030 (2005).
  • Supino PG, Borer JS, Herrold EM et al. Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest. Am. J. Cardiol.96(7), 964–970 (2005).
  • Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J. Am. Coll. Cardiol.53(20), 1829–1836 (2009).
  • Napodano M, Cutolo A, Fraccaro C et al. Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis. J. Thorac. Cardiovasc. Surg.138(4), 1027–1028 (2009).
  • Wenaweser P, Buellesfeld L, Gerkens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve prosthesis using the CoreValve revalving system. Catheter Cardiovasc. Interv.70, 760–764 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.